#USA #Boston #Interwell Health #Kidney Care #Tommy O'Connor

Interwell Health Welcomes Tommy O'Connor as CEO

On October 1, 2025, Interwell Health, the frontrunner in value-based kidney care, announced the appointment of Tommy O'Connor as its Chief Executive Officer. With a robust background in healthcare leadership, O'Connor is set to steer the company's mission to revolutionize kidney care through innovative, value-based solutions designed not only to enhance patient outcomes but also to cut costs effectively.

A New Era for Kidney Care

Tommy O'Connor's arrival marks a significant milestone for Interwell Health, especially following the strategic merger of Cricket Health, Interwell Health, and Fresenius Health Partners back in August 2022. Under this merger, the organization saw remarkable expansion, now partnering with over 2,300 nephrologists and managing care for over 145,000 patients across the nation. O'Connor, expressing his enthusiasm about leading the organization, commented on the passionate team at Interwell and their dedication towards making a meaningful impact for individuals living with kidney disease.

Experience that Transforms

Before his appointment at Interwell, O'Connor played a pivotal role as CEO for the Empire and Midwest Markets at UnitedHealthcare Medicare. He amassed invaluable expertise in building provider value-based partnerships, optimizing operations, and enhancing clinical outcomes at scale for approximately 1.1 million patients. O'Connor's strategic leadership fits seamlessly with Interwell's ongoing commitment to evolving comprehensive care models that adeptly address the complex requirements of chronic kidney disease (CKD) patients.

Driving Innovation and Excellence

Interwell's approach to care blends practical innovation with advanced technology. The company utilizes cutting-edge machine-learning algorithms alongside proprietary datasets, facilitating a comprehensive care coordination model that defines the largest value-based nephrology network in the U.S. This innovative framework aims to create not just sustainable savings but also remarkable quality results at a significant scale, serving patients with CKD across all stages, from stage 3 to kidney failure.

A Vision for the Future

Reflecting on his leadership transition, Tommy O'Connor highlighted how the momentum at Interwell Health underlines its status as a frontrunner within the government's value-based kidney care model. The company has been particularly lauded for its quality metrics and cost-effectiveness. By partnering with over 2,300 nephrologists, Interwell aims to deliver personalized care to patients across all 50 states and Puerto Rico, ensuring equitable access to vital resources.

As Interwell Health continues to expand its national footprint, O'Connor's leadership is expected to enhance innovations, improve outcomes for both patients and providers, and set new standards in the kidney care industry. His leadership promises a more integrated and sustainable model of care, enriching the lives of those with chronic kidney conditions and shaping the future landscape of healthcare.

Conclusion

With Tommy O'Connor at the helm, Interwell Health stands well-positioned to navigate the complexities of kidney care. The organization’s commitment to patient-centered approaches, operational excellence, and continual improvement ensures that they will not only meet the current needs of their patients but will also be prepared for the evolving challenges in the healthcare environment. For more information about Interwell Health and its initiatives, visit interwellhealth.com.